scholarly article | Q13442814 |
P356 | DOI | 10.1002/IJC.23374 |
P698 | PubMed publication ID | 18196576 |
P2093 | author name string | Tao Tang | |
Qian Tao | |||
Sai-Wah Tsao | |||
Grace Tin-Yun Chung | |||
Kwok-Wai Lo | |||
Kwong-Wai Choy | |||
Sylvia Yat-Yee Chan | |||
P4510 | describes a project that uses | C666-1 | Q54808229 |
CNE-1 | Q54813873 | ||
CNE-2 | Q54813874 | ||
HNE-1 | Q54890030 | ||
HNE-2 | Q54890031 | ||
NP460hTert | Q54930966 | ||
NP69SV40T | Q54930967 | ||
NPC/HK1 | Q54930981 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell line | Q21014462 |
P304 | page(s) | 2169-2171 | |
P577 | publication date | 2008-05-01 | |
P1433 | published in | International Journal of Cancer | Q332492 |
P1476 | title | Authentication of nasopharyngeal carcinoma tumor lines | |
P478 | volume | 122 |
Q38693867 | A Combination of Species Identification and STR Profiling Identifies Cross-contaminated Cells from 482 Human Tumor Cell Lines |
Q39550109 | A new naturally derived photosensitizer and its phototoxicity on head and neck cancer cells. |
Q57093338 | Air-Liquid Interface Method To Study Epstein-Barr Virus Pathogenesis in Nasopharyngeal Epithelial Cells |
Q24649032 | An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival |
Q42366441 | CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma. |
Q35673298 | Chick Chorioallantoic Membrane Assay: A 3D Animal Model for Study of Human Nasopharyngeal Carcinoma |
Q28077209 | Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis |
Q34262286 | Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes |
Q90429847 | Current Perspectives on Nasopharyngeal Carcinoma |
Q38493022 | Deregulation of lipid metabolism pathway genes in nasopharyngeal carcinoma cells |
Q37295787 | Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma |
Q60952463 | EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma |
Q93018091 | Epstein-Barr Virus and Innate Immunity: Friends or Foes? |
Q38826798 | Epstein-Barr virus LMP1 induces focal adhesions and epithelial cell migration through effects on integrin-α5 and N-cadherin |
Q58599820 | Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma |
Q54109268 | Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein-Barr virus reactivation. |
Q35333542 | Evaluation of stem-like side population cells in a recurrent nasopharyngeal carcinoma cell line |
Q37678950 | Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma. |
Q91861492 | Expression of Concern: Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma |
Q44232903 | Expression of Epstein‐Barr virus‐encodedLMP1andhTERTextends the life span and immortalizes primary cultures of nasopharyngeal epithelial cells |
Q38855783 | Gonadotropin‑releasing hormone inhibits the proliferation and motility of nasopharyngeal carcinoma cells |
Q64883108 | High COX-2 expression contributes to a poor prognosis through the inhibition of chemotherapy-induced senescence in nasopharyngeal carcinoma. |
Q35832185 | Identification of Four-Jointed Box 1 (FJX1)-Specific Peptides for Immunotherapy of Nasopharyngeal Carcinoma |
Q36047831 | Inhibition of nasopharyngeal carcinoma cell proliferation and synergism of cisplatin with silvestrol and episilvestrol isolated from Aglaia stellatopilosa |
Q52723933 | Interferon beta induces apoptosis in nasopharyngeal carcinoma cells via the TRAIL-signaling pathway. |
Q36255645 | Investigation of Cross-Contamination and Misidentification of 278 Widely Used Tumor Cell Lines |
Q59358007 | Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups |
Q88392173 | Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models |
Q42560502 | Quercetin-induced inhibition and synergistic activity with cisplatin - a chemotherapeutic strategy for nasopharyngeal carcinoma cells |
Q94554680 | Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21 |
Q35861281 | Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells. |
Q39025516 | Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress |
Q35076801 | The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent manner |
Q46528774 | The RARS-MAD1L1 Fusion Gene Induces Cancer Stem Cell-like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma. |
Q35117590 | Treatment of nasopharyngeal carcinoma cells with the histone-deacetylase inhibitor abexinostat: cooperative effects with cis-platin and radiotherapy on patient-derived xenografts |
Q41701781 | Zoledronic acid augments the radiosensitivity of cancer cells through perturbing S- and M-phase cyclins and p21CIP1 expression |
Search more.